Iron is an important micronutrient, but it can also act as a dangerous element by interfering with glucose homeostasis and inflammation, two features that are already disturbed in obese subjects. In this work, we study the effects of systemic iron supplementation on metabolic and inflammatory responses in mice with hypoferremia induced by obesity to better characterize whether iron worsens the parameters that are already altered after 24 weeks of a high-fat diet (HFD). Mice were maintained on a control diet or a HFD for 24 weeks and received iron-III polymaltose (50 mg/kg/every 2 days) during the last two weeks. Glucose homeostasis (basal glucose and insulin test tolerance) and systemic and visceral adipose tissue (VAT) inflammation were assessed. Iron levels were measured in serum. The Prussian blue reaction was used in isolated macrophages to detect iron deposition. Iron supplementation resulted in an increased number of VAT macrophages that were positive for Prussian blue staining as well as increased serum iron levels. Systemic hepcidin, leptin, resistin, and monocyte chemoattractant protein-1 (MCP-1) levels were not altered by iron supplementation. Local adipose tissue inflammation was also not made worse by iron supplementation because the levels of hepcidin, MCP-1, leptin, and interleukin (IL)-6 were not altered. In contrast, iron supplementation resulted in an increased production of IL-10 by adipose tissue and VAT macrophages. Leukocytosis and VAT plasminogen activator inhibitor-1 (PAI-1) level were reduced, but insulin resistance was not altered after iron supplementation. In conclusion, systemic iron supplementation in mice with hypoferremia induced by obesity did not worsen inflammatory marker or adipose tissue inflammation or the metabolic status established by obesity. Iron deposition was observed in adipose tissue, mainly in macrophages, suggesting that these cells have mechanisms that promote iron incorporation without increasing the production of inflammatory mediators.
SeltzerCCMayerJ. Serum iron and iron-binding capacity in adolescents. II. Comparison of obese and nonobese subjects. Am J Clin Nutr1963; 13: 354–61.
2.
WenzelBJStultsHBMayerJ. Hypoferraemia in obese adolescents. Lancet1962; 2: 327–8.
3.
WeisbergSPMcCannDDesaiMRosenbaumMLeibelRLFerranteAWJr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Investig2003; 112: 1796–808.
4.
SarvariAKDoan-XuanQMBacsoZCsomosIBalajthyZFesusL. Interaction of differentiated human adipocytes with macrophages leads to trogocytosis and selective IL-6 secretion. Cell Death Dis2015; 6: e1613.
5.
WrightingDMAndrewsNC. Interleukin-6 induces hepcidin expression through STAT3. Blood2006; 108: 3204–9.
RochetteLGudjoncikAGuenanciaCZellerMCottinYVergelyC. The iron-regulatory hormone hepcidin: a possible therapeutic target?Pharmacol Ther2015; 146C: 35–52.
8.
BekriSGualPAntyRLucianiNDahmanMRameshBIannelliAStaccini-MyxACasanovaDBen AmorISaint-PaulMCHuetPMSadoulJLGugenheimJSraiSKTranALe Marchand-BrustelY. Increased adipose tissue expression of hepcidin in severe obesity is independent from diabetes and NASH. Gastroenterology2006; 131: 788–96.
9.
GotardoEMSantosANMiyashiroRAGamberoSRochaTRibeiroMLGamberoA. Mice that are fed a high-fat diet display increased hepcidin expression in adipose tissue. J Nutr Sci Vitaminol2013; 59: 454–61.
10.
ZafonCLecubeASimoR. Iron in obesity. An ancient micronutrient for a modern disease. Obes Rev2010; 11: 322–8.
11.
BiswasSTapryalNMukherjeeRKumarRMukhopadhyayCK. Insulin promotes iron uptake in human hepatic cell by regulating transferrin receptor-1 transcription mediated by hypoxia inducible factor-1. Biochim Biophys Acta2013; 1832: 293–301.
12.
DavisRJCorveraSCzechMP. Insulin stimulates cellular iron uptake and causes the redistribution of intracellular transferrin receptors to the plasma membrane. J Biol Chem1986; 261: 8708–11.
13.
RumbergerJMPetersTJr.BurringtonCGreenA. Transferrin and iron contribute to the lipolytic effect of serum in isolated adipocytes. Diabetes2004; 53: 2535–41.
14.
FargionSDongiovanniPGuzzoAColomboSValentiLFracanzaniAL. Iron and insulin resistance. Aliment Pharmacol Ther2005; 22: 61–3.
15.
CookseyRCJonesDGabrielsenSHuangJSimcoxJALuoBSoesantoYRienhoffHAbelEDMcClainDA. Dietary iron restriction or iron chelation protects from diabetes and loss of beta-cell function in the obese (ob/ob lep-/-) mouse. Am J Physiol Endocrinol Metab2010; 298: E1236–43.
16.
RecalcatiSLocatiMGammellaEInvernizziPCairoG. Iron levels in polarized macrophages: regulation of immunity and autoimmunity. Autoimmun Rev2012; 11: 883–9.
17.
ZhangZZhangFAnPGuoXShenYTaoYWuQZhangYYuYNingBNieGKnutsonMDAndersonGJWangF. Ferroportin1 deficiency in mouse macrophages impairs iron homeostasis and inflammatory responses. Blood2011; 118: 1912–22.
18.
TajimaSIkedaYSawadaKYamanoNHorinouchiYKihiraYIshizawaKIzawa-IshizawaYKawazoeKTomitaSMinakuchiKTsuchiyaKTamakiT. Iron reduction by deferoxamine leads to amelioration of adiposity via the regulation of oxidative stress and inflammation in obese and type 2 diabetes KKAy mice. Am J Physiol Endocrinol Metab2012; 302: E77–86.
19.
ValentiLFracanzaniALDongiovanniPRovidaSRamettaRFattaEPulixiEAMaggioniMFargionS. A randomized trial of iron depletion in patients with nonalcoholic fatty liver disease and hyperferritinemia. World J Gastroenterol2014; 20: 3002–10.
20.
SonnweberTRessCNairzMTheurlISchrollAMurphyATWroblewskiVWitcherDRMoserPEbenbichlerCFKaserSWeissG. High-fat diet causes iron deficiency via hepcidin-independent reduction of duodenal iron absorption. J Nutr Biochem2012; 23: 1600–8.
21.
PintoLdFCompriCMFornariJVBartchewskyWCintraDETrevisanMCarvalho PdeORibeiroMLVellosoLASaadMJPedrazzoliJJr.GamberoA. The immunosuppressant drug, thalidomide, improves hepatic alterations induced by a high-fat diet in mice. Liver Int2010; 30: 603–10.
22.
LivakKJSchmittgenTD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods2001; 25: 402–8.
23.
MenzieCMYanoffLBDenkingerBIMcHughTSebringNGCalisKAYanovskiJA. Obesity-related hypoferremia is not explained by differences in reported intake of heme and nonheme iron or intake of dietary factors that can affect iron absorption. J Am Diet Assoc2008; 108: 145–8.
24.
NemethETuttleMSPowelsonJVaughnMBDonovanAWardDMGanzTKaplanJ. Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science2004; 306: 2090–3.
25.
BeckerCOrozcoMSolomonsNWSchumannK. Iron metabolism in obesity: how interaction between homoeostatic mechanisms can interfere with their original purpose. Part I: underlying homoeostatic mechanisms of energy storage and iron metabolisms and their interaction. J Trace Elem Med Biol2015; 30: 195–201.
26.
OrrJSKennedyAAnderson-BaucumEKWebbCDFordahlSCEriksonKMZhangYEtzerodtAMoestrupSKHastyAH. Obesity alters adipose tissue macrophage iron content and tissue iron distribution. Diabetes2014; 63: 421–32.
27.
HublerMJPetersonKRHastyAH. Iron homeostasis: a new job for macrophages in adipose tissue?Trends Endocrinol Metab2015; 26: 101–9.
28.
ZeydaMFarmerDTodoricJAszmannOSpeiserMGyoriGZlabingerGJStulnigTM. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes2007; 31: 1420–8.
29.
DrapierJCHirlingHWietzerbinJKaldyPKuhnLC. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBO J1993; 12: 3643–9.
30.
BoyleJJHarringtonHAPiperEElderfieldKStarkJLandisRCHaskardDO. Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype. Am J Pathol2009; 174: 1097–108.
31.
FinnAVNakanoMPolavarapuRKarmaliVSaeedOZhaoXYazdaniSOtsukaFDavisTHabibANarulaJKolodgieFDVirmaniR. Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques. J Am Coll Cardiol2012; 59: 166–77.
32.
Rojas JM, Sanz-Ortega L, Mulens-Arias V, Gutierrez L, Perez-Yague S, Barber DF. Superparamagnetic iron oxide nanoparticle uptake alters M2 macrophage phenotype, iron metabolism, migration and invasion. Nanomedicine 2016;12:1127–38.
33.
HerishanuYRogowskiOPolliackAMarilusR. Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol2006; 76: 516–20.
34.
LaharraguePOppertJMBroussetPCharletJPCampfieldAFontanillesAMGuy-GrandBCorberandJXPenicaudLCasteillaL. High concentration of leptin stimulates myeloid differentiation from human bone marrow CD34+ progenitors: potential involvement in leukocytosis of obese subjects. Int J Obes Relat Metab Dis2000; 24: 1212–6.
35.
Cousin B, Casteilla L, Laharrague P, Luche E, Lorsignol A, Cuminetti V, Paupert J. Immuno-metabolism and adipose tissue: the key role of hematopoietic stem cells. Biochimie 2016;124:21–6.
36.
CousinBAndreMArnaudEPenicaudLCasteillaL. Reconstitution of lethally irradiated mice by cells isolated from adipose tissue. Biochem Biophys Res Commun2003; 301: 1016–22.
37.
ChaiXLiDCaoXZhangYMuJLuWXiaoXLiCMengJChenJLiQWangJMengAZhaoM. ROS-mediated iron overload injures the hematopoiesis of bone marrow by damaging hematopoietic stem/progenitor cells in mice. Sci Rep2015; 5: 10181.
38.
LubranoCValacchiGSpecchiaPGnessiLRubanenkoEPShugininaEATrukhanovAIKorkinaLGDe LucaC. Integrated haematological profiles of redox status, lipid, and inflammatory protein biomarkers in benign obesity and unhealthy obesity with metabolic syndrome. Oxid Med Cell Longevity2015; 2015: 490613, .
39.
RadhaKSSugikiMHarish KumarMOmuraSMaruyamaM. Post-transcriptional regulation of plasminogen activator inhibitor-1 by intracellular iron in cultured human lung fibroblasts–interaction of an 81-kDa nuclear protein with the 3′-UTR. J Thromb Haemost2005; 3: 1001–8.
